Advertisement

Neonatology pp 967-992 | Cite as

Endocrine Diseases of Newborn

  • Paolo Ghirri
  • Antonio Balsamo
  • Massimiliano Ciantelli
  • Antonio Boldrini
  • Alessandro Cicognani

Abstract

Congenital hypopituitarism results from a deficiency of any or all of the hormones secreted by the anterior pituitary gland (adreno-corticotropic hormone [ACTH]; growth hormone [GH]; thyroid-stimulating hormone [TSH]; luteinizing hormone [LH]; follicle stimulating hormone [FSH]; prolactin [PRL]) or by the posterior pituitary gland (antidiuretic hormone [ADH]). It is uncommon. The annual incidence ranges from 1 to 42 new cases per million and a prevalence of 300– 455 cases per million [1].

Keywords

Adrenal Insufficiency Congenital Adrenal Hyperplasia Neonatal Diabetes Mellitus ACTH Deficiency Secondary Adrenal Insufficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Ascoli P, Cavagnini F (2006) Hypopituitarism. Pituitary 9: 235–242CrossRefGoogle Scholar
  2. 2.
    Osorio MG, Marui S, Jorge AA et al (2002) Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes. J Clin Endocrinol Metab 87: 5076–5084PubMedCrossRefGoogle Scholar
  3. 3.
    Alatzoglou KS, Dattani MT (2009) Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev 85: 705–712PubMedCrossRefGoogle Scholar
  4. 4.
    Coulter CL (2004) Functional biology of the primate fetal adrenal gland: advances in technology provide new insight. Clin Exp Pharmacol Physiol 31: 475–484PubMedCrossRefGoogle Scholar
  5. 5.
    Hanley NA, Arlt W (2006) The human fetal adrenal cortex and the window of sexual differentiation. Trends Endocrinol Metab 17: 391–397PubMedCrossRefGoogle Scholar
  6. 6.
    Goto M, Piper Hanley K et al (2006) In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest 116: 953–960PubMedCrossRefGoogle Scholar
  7. 7.
    Fujieda K, Tajima T(2005) Molecular basis of adrenal insufficiency. Ped Res 57: 62–69Google Scholar
  8. 8.
    Kempná P, Flück CE (2008) Adrenal gland development and defects. Best Pract Res Clin Endocrinol Metab 22: 77–93PubMedCrossRefGoogle Scholar
  9. 9.
    Balsamo A, Antelli A, Baldazzi L et al (2005) A new DAX1 gene mutation associated with congenital adrenal hypoplasia and hypogonadotropic hypogonadism. Am J Med Genet A 135: 292–296PubMedGoogle Scholar
  10. 10.
    Vilain E, Le Merrer M, Lecointre C et al (1999) IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies. J Clin Endocrinol Metab 84: 4335–4340PubMedCrossRefGoogle Scholar
  11. 11.
    Balsamo A, Cicognani A, Gennari M et al (2007) Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1. Eur J Endocrinol 156: 249–256PubMedCrossRefGoogle Scholar
  12. 12.
    Corzo D, Gibson W, Johnson K et al (2002) Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders. Am J Hum Genet 70: 1520–1531PubMedCrossRefGoogle Scholar
  13. 13.
    Raymond GV, Jones RO, Moser AB (2007) Newborn screening for adrenoleukodystrophy: implications for therapy. Mol Diagn Ther 11: 381–384PubMedGoogle Scholar
  14. 14.
    Clark AJ, Metherell LA, Cheetham ME, Huebner A (2005) Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends Endocrinol Metab 16: 451–457PubMedCrossRefGoogle Scholar
  15. 15.
    Langer M, Modi BP, Agus M (2006) Adrenal insufficiency in the critically ill neonate and child. Curr Opin Pediatr 18: 448–453PubMedCrossRefGoogle Scholar
  16. 16.
    Kam PC, Williams S, Yoong FF (2004) Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 59: 993–1001PubMedCrossRefGoogle Scholar
  17. 17.
    Spanakis E, Milord E, Gragnoli C (2008) AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol 217: 605–617PubMedCrossRefGoogle Scholar
  18. 18.
    Lin M, Liu SJ, Lim IT (2005) Disorders of water imbalance. Emerg Med Clin North Am 23: 749–770PubMedCrossRefGoogle Scholar
  19. 19.
    Ogilvy-Stuart A, Midgley P (2006) Hypernatraemia. In: Practical neonatal endocrinology. Cambridge University Press, New York, p 115CrossRefGoogle Scholar
  20. 20.
    Committee on Fetus and Newborn, Adamkin DH (2011) Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics 127: 575–579PubMedCrossRefGoogle Scholar
  21. 21.
    Metzger BE, Persson B et al; HAPO Study CooperativeResearch Group (2010) Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics 126: e1545–e1552PubMedCrossRefGoogle Scholar
  22. 22.
    Canadian Paediatric Society (2004) Screening guidelines for newborns at risk for low blood glucose. Paediatr Child Health 9: 723–740Google Scholar
  23. 23.
    Ghirri P, Ladaki C, Bartoli A et al (2007) Low birth weight for gestational age associates with reduced glucose concentrations at birth, infancy and childhood. Horm Res 67: 123–131PubMedCrossRefGoogle Scholar
  24. 24.
    Fourtner SH, Stanley CA (2004) Genetic and nongenetic forms of hyperinsulinism in neonates. Neoreviews 5: e370–e376CrossRefGoogle Scholar
  25. 25.
    Elliott M, Bayly R, Cole T et al (1994) Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin Genet 46: 168–174PubMedCrossRefGoogle Scholar
  26. 26.
    Weksberg R, Shuman C, Beckwith JB (2009) Beckwith–Wiedemann syndrome. Eur J Hum Genet 18: 8–14CrossRefGoogle Scholar
  27. 27.
    Rozance PJ, Hay WW Jr (2010) Neonatal hyperglycemia. Neoreviews 11: 632–639CrossRefGoogle Scholar
  28. 28.
    Bottino M, Cowett RM, Sinclair JC (2009) Interventions for treatment of neonatal hyperglycemia in very low birth weight infants. Cochrane Database Syst Rev 1:CD007453Google Scholar
  29. 29.
    Aguilar-Bryan L, Bryan J (2008) Neonatal diabetes mellitus. Endocr Rev 29: 265–291PubMedCrossRefGoogle Scholar
  30. 30.
    Colombo C, Porzio O, Liu M et al (2008) Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (SIEDP). Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest 118: 2148–2156PubMedGoogle Scholar
  31. 31.
    Bringhurst ER, Demay MB, Kronenberg HM (2008) Hormones and disorders of mineral metabolism. In: Kronenberg HM, Melmed S, Polonsky KS et al (eds) Williams Textbook of endocrinology, 11th edn. Saunders, Philadelphia, pp 1241–1249Google Scholar
  32. 32.
    Ogilvy-Stuart A, Midgerly P (2006) Hypocalcemia. In: Practical neonatal endocrinology. Cambridge University Press, New York, pp 133 - 142CrossRefGoogle Scholar
  33. 33.
    Ding C, Buckingham B, Levine MA (2001) Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest 108: 1215–1220PubMedGoogle Scholar
  34. 34.
    Bowl MR, Nesbit MA, Harding B et al (2005) An interstitial deletion- insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism. J Clin Invest 115: 2822–2831PubMedCrossRefGoogle Scholar
  35. 35.
    Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S (1999) A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism. J Clin Endocrinol Metab 84: 3792–3796PubMedCrossRefGoogle Scholar
  36. 36.
    Pearce SH, Williamson C, Kifor O et al (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium- sensing receptor. N Eng J Med 335: 1115–1122CrossRefGoogle Scholar
  37. 37.
    Farfel Z, Bourne H, Iiri T (1999) The expanding spectrum of G protein disease N Eng J Med 340: 1012–1020Google Scholar
  38. 38.
    Newfield RS (2007) Recombinant PTH for initial management of neonatal hypocalcemia. N Engl J Med 356: 1687–1688PubMedCrossRefGoogle Scholar
  39. 39.
    Ghirri P, Bottone U, Coccoli L et al (1999) Symptomatic hypercalcemia in the first months of life: calcium-regulating hormones and treatment. J Endocrinol Invest 22: 349–353PubMedGoogle Scholar
  40. 40.
    Peters CJ, Hindmarsh PC (2007) Management of neonatal endocrinopathies - Best practice guidelines. Early Hum Dev 83: 553–561PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Paolo Ghirri
  • Antonio Balsamo
  • Massimiliano Ciantelli
  • Antonio Boldrini
  • Alessandro Cicognani
    • 1
  1. 1.Department of Gynecologic, Obstetric and Pediatric SciencesUniversity and S. Orsola-Malpighi HospitalBolognaItaly

Personalised recommendations